RxDoctor Payments Data

Christopher Perro, MD

Otolaryngology/Facial Plastic Surgery · Tyler, TXNPI 1346462496

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,211 of the $1,606 with a category attached, or 75.4%. 13 manufacturers reported payments, led by Smith+Nephew at 34.8% of the total. Reporting peaked in 2024 at $561 and has fallen 96.7% since, to $19 in 2025. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in TX, where the typical reported total is $1,846.

$1,606in general payments, 2019–2025

Across 45 payments — averaging $35.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$558
  • Stryker$405
  • AbbVie$216
  • Galderma Laboratories, L.p.$134
  • Inspire Medical Systems, Inc.$114
  • Regeneron Healthcare Solutions, Inc.$39
  • plus $141 from 7 others

What the payments were for

  • Travel & lodging$39525%
  • Food & beverage$1,21175%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,606 in reported general payments places this provider in the 40th percentile of 51 otolaryngology/facial plastic surgery providers in Texas.

See all otolaryngology/facial plastic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$130,946
Medicare patients
343
Services billed
990

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide455$10,734
Azelastine Hcl216$5,639
Fluticasone Propionate238$2,854
Ofloxacin89$1,780
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$1,652
Pantoprazole Sodium173$1,323
Famotidine143$1,190
Mometasone Furoate34$975
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav58$852
Pilocarpine Hcl26$777
Mupirocin78$650
Nystatin13$297
Levofloxacin19$184
Methylprednisolone23$147
Cephalexin11$117

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Tyler

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →